https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46791 Wed 30 Nov 2022 13:21:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50459 Wed 26 Jul 2023 13:49:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22025 Wed 11 Apr 2018 14:59:42 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31263 Wed 11 Apr 2018 14:12:59 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24534 Wed 11 Apr 2018 12:18:12 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24881 Wed 11 Apr 2018 12:10:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:16789 Wed 11 Apr 2018 10:04:12 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34992 Wed 10 Jun 2020 11:54:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48763 Wed 05 Apr 2023 13:49:33 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30821 Wed 02 Mar 2022 14:27:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36555 Tue 30 Jun 2020 11:51:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:33134 Tue 28 Aug 2018 13:03:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36464 Tue 12 May 2020 13:50:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23545 Tue 11 Dec 2018 16:03:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52399 Tue 10 Oct 2023 18:07:39 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45993 Tue 08 Nov 2022 15:29:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29096 Thu 26 Jul 2018 13:18:04 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51390 Thu 23 Nov 2023 14:31:06 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53402 Thu 23 Nov 2023 13:43:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35993 Thu 23 Jan 2020 14:49:14 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52240 Thu 05 Oct 2023 11:54:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:8350 Sat 24 Mar 2018 10:47:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:7628 Sat 24 Mar 2018 08:34:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:1713 50% reduction in disability were glucose-lignocaine: 0.42 versus saline 0.36 and exercise: 0.36 versus normal activity: 0.38. There were no between group differences in any of the above measures. Conclusions. In chronic nonspecific low-back pain, significant and sustained reductions in pain and disability occur with ligament injections, irrespective of the solution injected or the concurrent use of exercises.]]> Sat 24 Mar 2018 08:27:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:13712 Sat 24 Mar 2018 08:24:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9989 Sat 24 Mar 2018 08:14:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20056 Sat 24 Mar 2018 08:00:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20902 Sat 24 Mar 2018 07:57:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:17681 Sat 24 Mar 2018 07:57:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20116 Sat 24 Mar 2018 07:51:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30098 Sat 24 Mar 2018 07:37:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27393 Sat 24 Mar 2018 07:34:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29712 P = 0.831), ODI (OR, 1.00; 95% CI 0.52–1.92; P = 0.996), SF-12 PCS (OR, 1.09; 95% CI 0.58–2.04; P = 0.791), and EQ-5D (OR, 0.62; 95% CI 0.32–1.21; P = 0.164). Disease-specific subgroup analyses confirmed the results. Conclusions: The present data suggest that patients with pBP have comparable functional and health-related quality of life outcomes after surgery for LDH or LSS with those of patients with pLP.]]> Sat 24 Mar 2018 07:33:26 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27178 Sat 24 Mar 2018 07:31:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25697 Sat 24 Mar 2018 07:28:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38476 n = 2136, 96.4%), low back pain without specific etiology (n = 1,863, 84.1%), and chronic duration (n = 947, 42.8%). The quality of trials improved over time; however, most were at risk of bias. Less than half of the trials concealed allocation to intervention (n = 813, 36.7%), used intention-to-treat principles (n = 778, 35.1%), and blinded assessors (n = 810, 36.6%), participants (n = 174, 7.9%), and therapists (n = 39, 1.8%). These findings did not vary by the type of therapy. Conclusion: Most trials that test physical therapy interventions for low back pain have methodological limitations that could bias treatment effect estimates. Greater attention to methodological features, such as allocation concealment and the reporting of intention-to-treat effects, would improve the quality of trials testing physical therapy interventions for low back pain.]]> Mon 29 Jan 2024 18:05:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46608 P = 0.76; joint modelling CACE 0.23 [-0.16 to 0.62] P = 0.24; intention-to-treat 0.11 [-0.20 to 0.42] P = 0.49; per protocol 0.29 [-0.07 to 0.65] P = 0.12); results for secondary outcomes and for exploratory analyses were similar. Paracetamol is ineffective for acute LBP even for patients who comply with treatment. This reinforces the notion that management of acute LBP should focus on providing patients advice and reassurance without the addition of paracetamol.]]> Mon 28 Nov 2022 08:58:25 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34278 Mon 25 Feb 2019 14:55:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44793 Mon 24 Oct 2022 09:17:55 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:20555 Mon 18 Mar 2019 12:45:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:52344 50 years of age versus > 70 years of age) across different studies, as this has previously been shown to influence results.]]> Mon 09 Oct 2023 14:57:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51903 3 months) nonspecific low back pain from primary care and community settings. A total of 276 adults were randomized (in a 1:1 ratio) to the intervention or sham procedure and attention control groups delivered by clinicians at a medical research institute in Sydney, Australia. The first participant was randomized on December 10, 2015, and the last was randomized on July 25, 2019. Follow-up was completed on February 3, 2020. Interventions: Participants randomized to the intervention group (n = 138) were asked to participate in 12 weekly clinical sessions and home training designed to educate them about and assist them with movement and physical activity while experiencing lower back pain. Participants randomized to the control group (n = 138) were asked to participate in 12 weekly clinical sessions and home training that required similar time as the intervention but did not focus on education, movement, and physical activity. The control group included sham laser and shortwave diathermy applied to the back and sham noninvasive brain stimulation. Main Outcomes and Measures: The primary outcome was pain intensity at 18 weeks, measured on an 11-point numerical rating scale (range, 0 [no pain] to 10 [worst pain imaginable]) for which the between-group minimum clinically important difference is 1.0 point. Results: Among 276 randomized patients (mean [SD] age, 46 [14.3] years; 138 [50%] women), 261 (95%) completed follow-up at 18 weeks. The mean pain intensity was 5.6 at baseline and 3.1 at 18 weeks in the intervention group and 5.8 at baseline and 4.0 at 18 weeks in the control group, with an estimated between-group mean difference at 18 weeks of -1.0 point ([95% CI, -1.5 to -0.4]; P =.001), favoring the intervention group. Conclusions and Relevance: In this randomized clinical trial conducted at a single center among patients with chronic low back pain, graded sensorimotor retraining, compared with a sham procedure and attention control, significantly improved pain intensity at 18 weeks. The improvements in pain intensity were small, and further research is needed to understand the generalizability of the findings. Trial Registration: ANZCTR Identifier: ACTRN12615000610538.]]> Fri 22 Sep 2023 10:11:12 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53877 Fri 19 Jan 2024 12:40:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35452 Fri 16 Aug 2019 15:08:31 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23092 Fri 09 Aug 2019 14:04:14 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51526 Fri 08 Sep 2023 12:11:44 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54697 Fri 08 Mar 2024 12:06:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35772 3 months in duration) and body mass index ≥27 kg/m² and <40 kg/m² were randomly allocated, using a central concealed random allocation process, to receive advice and education and referral to a 6-month telephone-based healthy lifestyle coaching service, or usual care. The primary outcome was pain intensity measured using an 11-point numerical rating scale, at baseline, 2 weeks, and monthly for 6 months. Data analysis was by intention-to-treat according to a prepublished analysis plan. Between May 13, 2015, and October 27, 2015, 160 patients were randomly assigned in a 1:1 ratio to the intervention or usual care. We found no difference between groups for pain intensity over 6 months (area under the curve, mean difference = 6.5, 95% confidence interval -8.0 to 21.0; P = 0.38) or any secondary outcome. In the intervention group, 41% (n = 32) of participants reported an adverse event compared with 56% (n = 45) in the control group. Our findings show that providing education and advice and telephone-based healthy lifestyle coaching did not benefit patients with low back pain who were overweight or obese, compared with usual care. The intervention did not influence the targeted healthy lifestyle behaviours proposed to improve pain in this patient group.]]> Fri 03 Dec 2021 10:32:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:36377 Fri 03 Apr 2020 16:03:32 AEDT ]]>